Imaging

Microburst VNS: individualized epilepsy treatment 2:56
Microburst VNS: individualized epilepsy treatment
Cornelia Drees • 25 May 2023
MS therapies: limited direct effect in CNS pathology 2:29
MS therapies: limited direct effect in CNS pathology
Augusto A. Miravalle • 5 May 2023
Imaging glymphatic flow in animal models 1:09
Imaging glymphatic flow in animal models
Ian Harrison • 25 Apr 2023
Latest developments in Parkinson’s disease biomarkers 6:10
Latest developments in Parkinson’s disease biomarkers
Andrea Pilotto • 23 Mar 2023
Brain imaging signatures to predict conversion risk in iRBD 1:25
Brain imaging signatures to predict conversion risk in iRBD
Shady Rahayel • 16 Apr 2023
Brain atrophy in iRBD is driven by mitochondrial function-associated genes 7:12
Brain atrophy in iRBD is driven by mitochondrial function-associated genes
Shady Rahayel • 16 Mar 2023
Inclusion of optical nerve lesions the McDonald diagnostic criteria 4:18
Inclusion of optical nerve lesions the McDonald diagnostic criteria
Giancarlo Comi • 27 Mar 2023
TSPO-PET imaging in MS clinical trials and treatment decisions 1:24
TSPO-PET imaging in MS clinical trials and treatment decisions
Laura Airas • 16 Feb 2023
Using advanced imaging in daily stroke practice 1:25
Using advanced imaging in daily stroke practice
James E. Siegler • 13 Feb 2023
Advancements in MS imaging techniques: spinal cord imaging 1:06
Advancements in MS imaging techniques: spinal cord imaging
Lisa Eunyoung Lee • 1 Mar 2023
Myelin abnormalities in the cervical spinal cord associated with clinical disability in MS subtypes 2:16
Myelin abnormalities in the cervical spinal cord associated with clinical disability in MS subtypes
Lisa Eunyoung Lee • 1 Mar 2023
Infectious mimickers of MS 6:01
Infectious mimickers of MS
Lorna Galleguillos • 16 Feb 2023
CSF biomarker-based models to predict MS outcomes 3:09
CSF biomarker-based models to predict MS outcomes
Peter Kosa • 28 Feb 2023
Impact of natalizumab on chronic active MS lesions 3:33
Impact of natalizumab on chronic active MS lesions
Laura Airas • 16 Feb 2023
Serum proteins associated with glial cell injury, MRI measures & neuropsychological outcomes in MS 4:03
Serum proteins associated with glial cell injury, MRI measures & neuropsychological outcomes in MS
Ferhan Qureshi • 27 Feb 2023
Quantitative spinal cord magnetic resonance imaging in MS: value & challenges 2:18
Quantitative spinal cord magnetic resonance imaging in MS: value & challenges
Lisa Eunyoung Lee • 1 Mar 2023
The content of VJNeurology is intended for healthcare professionals